Study Details
Full Title
A double-blind, randomised, placebo-controlled, parallel group, Phase IIa trial to evaluate safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of BI 765423 administered intravenously with or without standard of care in patients with idiopathic pulmonary fibrosis (IPF)
BI 1493-0002
BI 1493-0002
Principal Investigator
Lake
Morrison
Protocol Number
PRO00119034
NCT ID
NCT07036523
Phase
II
Enrollment Status
Open to Enrollment